Research Interests:

Research in Dr. Leving’s laboratory is focused on a subset of CD4+ T cells, termed T regulatory (Treg) cells, which control immune homeostasis. Current work in the Leving laboratory is focused on determining how Treg cells differ from normal CD4+ T cells at both the biochemical and molecular levels, and elucidating their role in transplantation tolerance and autoimmunity. Their long-term goal is to develop methods to generate Treg cells in vitro for use as a cellular therapy to replace standard immunosuppression in the context of organ transplantation or to restore tolerance in the context of autoimmunity.

Contributions

New World of targeted therapies (targets, delivery systems,new molecules) - Discussion and Q&ANew World of targeted therapies (targets and delivery systems and new molecules)90th EAS Congress 2022Cell based therapies in atherosclerosisNew World of targeted therapies (targets and delivery systems and new molecules)90th EAS Congress 2022